The independent source for health policy research, polling, and news.
821 - 840 of 3,889 Results
The Centers for Medicare & Medicaid Services backed off from a plan that could have curtailed access to a type of reconstructive surgery known as DIEP flap. Breast cancer patient advocates are relieved.
Mandy Cohen, the new director of the Centers for Disease Control and Prevention, earned praise for her leadership and communication as the face of North Carolina’s response to covid-19. People in the state’s most vulnerable communities tell a more complicated story.
Prior authorization is a common tool used by health insurers for many tests, procedures, and prescriptions. Frustrated by the process, patients and doctors have turned to social media to publicly shame insurance companies and elevate their denials for further review.
Community health workers, who often help patients get to their appointments and pick up prescriptions for them, have increasingly been recognized as an integral part of treating chronic illnesses. But state-run Medicaid programs don’t always reimburse them equally, usually excluding those who work on tribal lands.
In early 2020, U.S. public health labs received covid-19 tests from the Centers for Disease Control and Prevention that were flawed, as a result of poor design and contamination. Now the CDC is overhauling its lab operations, but efforts to be better prepared for future threats won’t be easy, observers say.
Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development required to bring them to market nor their therapeutic value, recent research shows. Have drugmakers overplayed their hand?
A Tulsa-based gas station chain is using its knowledge of how to serve customers and locate shops in easy-to-find spots to enter the urgent care industry, which has doubled in size over the past decade. Experts question how the explosion of convenient clinics will affect care costs and wait times.
The No Surprises Act has helped rein in out-of-network medical bills, but ground ambulances are a costly exception. Hear why this service can still hit patients with big bills and what to do if you get one.
Federal officials are trying to clamp down on private arrangements among some hospitals to pay themselves back for the Medicaid taxes they’ve paid. State health officials and the influential hospital industry argue that regulators have no jurisdiction over the agreements.
An analysis of court records by the state treasurer and Duke researchers finds Atrium Health, originally a public hospital system, accounted for almost a third of the legal actions against North Carolina patients over roughly five years.
Kaiser Permanente, the California-based health care giant, is looking to dramatically expand its national presence. It’s committed $5 billion to a new unit called Risant Health and has agreed to acquire Pennsylvania-based Geisinger, but skeptics wonder how it will export its unique model to other states.
A Biden administration proposal would help standardize the data on prices that hospitals provide to patients, increase its usefulness to consumers, and boost enforcement. Previous rules gave hospitals too many loopholes.
PBS NewsHour featured KFF Health News’ Aneri Pattani as it reported on how this debate is playing out in North Carolina and Ohio.
Clinics serving Alzheimer’s patients are working out the details of who will get treated with the new drug Leqembi. It won’t be for everyone with memory-loss symptoms.
After decades of unchecked mergers, health care is the land of giants, with huge medical systems monopolizing care in many cities, states, and even whole regions of the country. This decreases patient choice, impedes innovation, erodes quality of care, and raises prices. And federal regulators have been slow to act.
The first of a new wave of cancer-detection blood tests likely saved Gilbert Milam Jr.’s life. But many cancer researchers, wary of overtesting, argue it’s premature to prescribe the Galleri test widely.
Nearly a year to the day after Kansas voters surprised the nation by defeating an anti-abortion ballot question, Ohio voters defeated a similar, if cagier, effort to limit access in that state. This week, they rejected an effort to raise the threshold for approval of future ballot measures from a simple majority, which would have made it harder to protect abortion access with yet another ballot question come November. Meanwhile, the number of Americans without health insurance has dropped to an all-time low, though few noticed. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Roubein of The Washington Post, and Emmarie Huetteman of KFF Health News join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews Kate McEvoy, executive director of the National Association of Medicaid Directors, about how the “Medicaid unwinding” is going, as millions have their eligibility for coverage rechecked.
The new Montana law contains a couple of significant differences from the measure voters rebuffed last fall.
A union is asking Los Angeles city voters to cap hospital executive pay at the U.S. president’s salary. However, hospitals accuse the union of using the proposal as political leverage, and policy experts question whether the policy, if enacted, would be workable.
Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.
© 2026 KFF